Atlas Trials

Acute Respiratory Viral Infections

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Respiratory Viral Infections

RecordFirmDate
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions. (NCT07645534)Valenta Pharm JSC2025-07-11
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI (NCT03830905)PHARMENTERPRISES LLC2019-01-31
Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections (NCT03707912)Materia Medica Holding2018-10-09
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections (NCT03455491)PHARMENTERPRISES LLC2018-02-12
Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children (NCT03039621)Materia Medica Holding2016-10-07
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza. (NCT04682444)Joint Stock Company "Farmak"2009-04-13

Track Acute Respiratory Viral Infections automatically

Every clearance here is in the API, with alerts when new ones post.